SeaSpine pushes limited commercial launch of Skipjack: 5 highlights Featured

Written by  Megan Wood | Friday, 14 July 2017 16:52
Social sharing

SeaSpine reported the limited commercial launch of its Skipjack Expandable Interbody System.

Here are five highlights:


1. Surgeons have completed the initial cases with the Skipjack Expandable Interbody System.


2. The Skipjack features patented technology acquired from the NLT Spine in 2016.


3. The system is intended to offer continuous in-situ expansion in height or lordosis for a personalized fit.


4. The in-situ expansion is designed to limit tissue disruption and decrease endplate damage.


5. From a posterior approach, the Skipjack offers up to 20 degrees of lordotic correction.


More articles on devices:
Pinnacle Spine receives US patent for in situ graft delivery technology: 5 key points
Medicrea reports 41% jump in UNiD ASI systems revenue for first half of 2017 — 8 things to know
Aurora Spine receives $350k loan from company insider: 6 insights


© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months